AZD-8233

N/A

Report date: 2022/10/22 20:01:21
NME

Base Information

Drug NameAZD-8233
Drug Alias NameAZD-8233IONIS-AZ4-2.5-LRxION-449
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHypercholesterolemiaHyperlipidemiasDyslipidemias +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesSlovakia +[10] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc
Inactive CompaniesAstrazeneca AbAstraZeneca global R & D (China) Co Ltd
Active IndicationsHyperlipidemiasDyslipidemias
Inactive IndicationsHypercholesterolemiaKidney Failure, Chronic

Other Information

ATC CodeN/A
Related LinksN/A